跳至主要内容
临床试验/ITMCTR2022000054
ITMCTR2022000054尚未招募1 期

Clinical observation and central mechanism of acupoint catgut embedding in the treatment of chronic spontaneous urticaria based on functional magnetic resonance imaging

Guang 'anmen Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 60(—)
性别
All

入选标准

  • 1. Age between 18 and 60, regardless of gender.
  • 2. Meet the diagnostic criteria of chronic spontaneous urticaria: the onset of wind masses every day or intermittently, each duration of no more than 24 hours, the duration of > 6 weeks.
  • 3. Despite the use of H1 antihistamines, wind masses and pruritus were present for at least 6 weeks prior to enrollment; At least once a day, mainly wind mass and pruritus, without serious systemic symptoms.
  • 4. 7-day urticaria activity score (UAS)=16 points, weekly pruritus score = 8 points.
  • 5. Right-handed.
  • 6. No history of catgut embedding.
  • 7. Sign informed consent, voluntarily and agree to complete all steps of the clinical study.

排除标准

  • 1. Clear cause of chronic urticaria (such as physical urticaria);
  • 2. Glucocorticoid, hydroxychloroquine, methotrexate, cyclosporine, cyclophosphamide, or intravenous immunoglobulin for any indication (daily, or more than 3 consecutive other days) received during the first 30 days of enrollment;
  • 3. Received any H2 antihistamine, leukotriene receptor antagonist, omalizumab and other biological agents 7 days before screening and 14 days before randomization;
  • 4. Three days before screening, H1 antihistamines exceeded the permitted dose;
  • 5. Complicated with serious cardiovascular and cerebrovascular diseases, diabetes, abnormal bone metabolism and other diseases, or liver and kidney diseases, hematopoietic system and other serious primary diseases; Patients with systemic lupus erythematosus and other serious autoimmune diseases;
  • 6. Diseases other than chronic urticaria with symptoms of urticaria or angioedema, such as urticaria vasculitis, Erythema multiform, cutaneous mastocytosis (pigmentary urticaria) and hereditary or acquired angioedema (e.g., due to deficiency of C1 inhibitor);
  • 7. Skin diseases related to chronic pruritus (e.g., atopic dermatitis, bullous pemphigus, herpetic dermatitis, pruritus in old age, etc.) that may affect the evaluation and treatment of the study;
  • 8. People allergic to buried wire materials;
  • 9. Women with fertility needs, pregnancy and lactation during the study period;
  • 10. Contraindicated mri patients;
  • 11. Participating in or participating in other clinical trials within the last 3 months;
  • 12. Used psychotropic drugs within the past month.

研究者

发起方
Guang 'anmen Hospital

相似试验